Nov 3, 2014, 00:00 AM by Michael Croft

SHIRLEY, NY - Nov 3, 2014 - Bioanalytical services help scientists to get more scientific findings. The professional team of Creative Animodel provides creative bioanalysis services, assuring the quality and cost of its services and products

Nov 3, 2014, 00:00 AM by Michael Croft

PRINCETON, NJ - Nov 3, 2014 - Certara®, the leading global technology-enabled drug development and drug safety consultancy, today announced the launch of version 1

Nov 3, 2014, 00:00 AM by Michael Croft

SHIRLEY, NY - Nov 3, 2014 - Bioanalytical services help scientists to get more scientific findings. The professional team of Creative Animodel provides creative bioanalysis services, assuring the quality and cost of its services and products

Oct 31, 2014, 09:30 AM by Michael Croft

Bio-IT World | Dutch startup MIMETAS, whose microfluidics technology forms a platform for three-dimensional, multi-cell-type tissue cultures, is securing new funding and partnerships as it expands its line of drug screening models.

Oct 30, 2014, 00:00 AM by Michael Croft

NEW YORK, NY - Oct 30, 2014 - Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it has signed an enterprise agreement with ASLAN Pharmaceuticals, an oncology-focused biotechnology company

Oct 29, 2014, 08:40 AM by Michael Croft

Nature News | With mass sequencing of humans now a practical reality, several large population studies are searching for people with rare mutations that completely knock out specific genes, to uncover these genes' functions and potentially new drug targets.

Oct 28, 2014, 00:00 AM by Michael Croft

VANCOUVER, BC, CANADA - Oct 28, 2014 - An exciting new research project that aims to make personalized medicine a reality for patients is launching in a number of community pharmacies across British Columbia

Oct 28, 2014, 00:00 AM by Michael Croft

WARSAW, POLAND - Oct 28, 2014 - KCR, a European Contract Research Organization (CRO) operating across 19 European countries and in the US, has turned to the cloud in a move to improve cross-functional collaboration and trial operations

Oct 27, 2014, 08:45 AM by Michael Croft

Xconomy | Syros Pharmaceuticals, a biotech focused on creating drugs that target gene expression regulatory pathways, has announced a $53 million Series B financing round.

Oct 27, 2014, 00:00 AM by Michael Croft

LANCASTER, CA - Oct 27, 2014 - Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for discovery and development, announced that The Dow Chemical Company (NYSE: DOW) has licensed both its best-in-class Full story

Oct 26, 2014, 00:00 AM by Michael Croft

SHIRLEY, NY - Oct 26, 2014 - Whole genome resequencing is a laboratory process that determines the complete DNA sequence of an organism's genome which is already known

Oct 24, 2014, 13:25 PM by Michael Croft

MIT Technology Review | Since the FDA made clear last November that it would not tolerate companies selling genetic tests linked to health reports without regulatory approval, a workaround for customers of companies like 23andMe has emerged online.

Oct 23, 2014, 14:15 PM by Michael Croft

Bio-IT World News Brief | A paper published today in Science describes a new type of fluorescence microscope that is capable of taking images of living, three-dimensional systems over long periods of time without degrading cells or fluorescent molecules.

Oct 23, 2014, 00:00 AM by Michael Croft

ST. LOUIS, MO - Oct 23, 2014 - Certara®, the leading global technology-enabled drug development and drug safety consultancy, today announced that it has received a Food and Drug Administration (FDA) Office of Generic Drugs grant (#1 U01 FD005225-01) to further develop and validate its Simcyp® Simulator’s mechanistic dermal absorption model, MechDermA

Oct 23, 2014, 00:00 AM by Michael Croft

ST. LOUIS, MO - Oct 23, 2014 - Certara®, the leading global technology-enabled drug development and drug safety consultancy, today announced that it has received a Food and Drug Administration (FDA) Office of Generic Drugs grant (#1 U01 FD005225-01) to further develop and validate its Simcyp® Simulator’s mechanistic dermal absorption model, MechDermA

Oct 22, 2014, 08:50 AM by Michael Croft

Bio-IT World | At the FDA's Center for Biologics Evaluation and Research, a custom distributed computing system called HIVE takes a new approach to storing and analyzing huge sets of genomic and other biological data.

Oct 22, 2014, 00:00 AM by Michael Croft

TORONTO, CANADA - Oct 22, 2014 - Voltage-gated sodium channels are a class of large integral membrane proteins, composed of a highly processed α subunit and one or several smaller β subunits

Oct 21, 2014, 09:45 AM by Michael Croft

Bio-IT World News Brief | Edico Genome, a San Diego-based company manufacturing application-specific integrated circuits for processing genomic data, this week announced the broad commercial launch of its flagship DRAGEN processor.

Oct 21, 2014, 00:00 AM by Michael Croft

CHAPEL HILL, NC, UNITED STATES - Oct 21, 2014 - Rho, a contract research organization (CRO) providing clinical research services in both the commercial and federal market, has been awarded the renewal of their existing federal contract with the National Institute of Dental and Craniofacial Research (NIDCR)

Oct 21, 2014, 00:00 AM by Michael Croft

CAMBRIDGE, MA, UNITED STATES - Oct 21, 2014 - Seven Bridges Genomics, Inc. announced today that it has been awarded a 5.8 million dollar contract as a part of the National Cancer Institute’s Cancer Genomics Cloud Pilot Initiative